Retrovirus

SEATTLE — Thirty years after he helped start the Conference on Retroviruses and Opportunistic Infections, the medical conference helped honor Anthony S. Fauci, MD, for his work on HIV and other infectious diseases.

Several knowledge gaps remain in xenotransplantation despite the successful procedure of a porcine kidney into a brain-dead recipient, according to a presentation at the 2022 Innovations in Dialysis: Expediting Advances Symposium.

The Lupus Research Alliance has awarded the 2022 Lupus Insight Prize to Akiko Iwasaki, PhD, for her work connecting endogenous retroviruses and systemic lupus erythematosus.

Organizers announced Tuesday that the Conference on Retroviruses and Opportunistic Infections will be an entirely virtual meeting for the third year in a row because of COVID-19.

In preparation for the second consecutive all-virtual Conference on Retroviruses and Opportunistic Infections, organizers aimed to improve digital components of the meeting, said conference chair Sharon L. Hillier, PhD.

The Conference on Retroviruses and Opportunistic Infections is being held virtually for the second year in a row because of COVID-19.

Administered as an injection every 2 months, the investigational drug cabotegravir was 69% more effective at preventing HIV than currently approved pre-exposure prophylaxis, or PrEP, ViiV Healthcare said today.

Phase 1 dose-escalation clinical trial to determine the phase 2 dose of autologous TIL 1383I TCR gene-modified T cells using a retrovirus for patients with advanced melanoma.

With more than 25 years of experience investigating HIV, Daniel Kuritzkes, MD, chief of the division of infectious diseases at Brigham & Women’s Hospital and professor at Harvard Medical School, puts into context the strides the community has made toward eradicating HIV in the past several years.